Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R21NS108015-02
Neural and non-neural contributions to phenotype in human SMA type 1
European Commission
Grant: 617351
microRNAs confer robustness to adult beta–cell identity
National Institutes of Health
Grant: 5R01HD054599-02
Therapeutic Opportunities in Spinal Muscular Atrophy
Fields of Study
Keywords
Sustainable Development Goals